Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
76
datasets available to search
ShareScore release 0.9.0
Dataset results
76 results for “anticancer drug”
A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs
ClinicalTrials.gov study NCT07336446. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer
ClinicalTrials.gov study NCT05111561. IPD Sharing: YES. Countries: 1. Publications: 0.
The Role of the EKG in Anticancer Drug Development
ClinicalTrials.gov study NCT01462383. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer
ClinicalTrials.gov study NCT04394858. IPD Sharing: YES. Countries: 1. Publications: 0.
Novel FOXM1 Inhibitor STL001 sensitizes different human cancers to broad spectrum of anticancer drugs
GEO Series GSE261182. Homo sapiens. 10 samples. Type: Expression profiling by high throughput sequencing.
Perturbation-informed signatures from crosswise integration of transcriptome and chromatin accessibility analyses predict susceptibility to candidate anticancer drugs (cisplatin validation dataset) [A
GEO Series GSE207607. Homo sapiens. 16 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
Drug-induced change in gene expression across NCI-60 cell lines after exposure to 15 anticancer agents for 2, 6 and 24h (5-Azacytidine)
GEO Series GSE116437. Homo sapiens. 440 samples. Type: Expression profiling by array.
Drug-induced change in gene expression across NCI-60 cell lines after exposure to 15 anticancer agents for 2, 6 and 24h (lapatinib)
GEO Series GSE116445. Homo sapiens. 485 samples. Type: Expression profiling by array.
Drug-induced change in gene expression across NCI-60 cell lines after exposure to 15 anticancer agents for 2, 6 and 24h (gemcitabine)
GEO Series GSE116444. Homo sapiens. 495 samples. Type: Expression profiling by array.
Drug-induced change in gene expression across NCI-60 cell lines after exposure to 15 anticancer agents for 2, 6 and 24h (erlotinib)
GEO Series GSE116442. Homo sapiens. 536 samples. Type: Expression profiling by array.
Drug-induced change in gene expression across NCI-60 cell lines after exposure to 15 anticancer agents for 2, 6 and 24h (bortezomib)
GEO Series GSE116438. Homo sapiens. 525 samples. Type: Expression profiling by array.
Perturbation-informed signatures from crosswise integration of transcriptome and chromatin accessibility analyses predict susceptibility to candidate anticancer drugs
GEO Series GSE179064. Homo sapiens. 60 samples. Type: Expression profiling by high throughput sequencing; Genome binding/occupancy profiling by high throughput sequencing.
Drug-induced change in gene expression across NCI-60 cell lines after exposure to 15 anticancer agents for 2, 6 and 24h
GEO Series GSE116436. Homo sapiens. 7623 samples. Type: Expression profiling by array.
Transcriptome Analysis Predicts Clinical Outcome and Sensitivity to Anticancer Drugs of patients with a Pancreatic Adenocarcinoma
GEO Series GSE55513. Homo sapiens. 34 samples. Type: Expression profiling by array.
Drug-induced change in gene expression across NCI-60 cell lines after exposure to 15 anticancer agents for 2, 6 and 24h (sirolimus)
GEO Series GSE116447. Homo sapiens. 507 samples. Type: Expression profiling by array.
Drug-induced change in gene expression across NCI-60 cell lines after exposure to 15 anticancer agents for 2, 6 and 24h (paclitaxel)
GEO Series GSE116446. Homo sapiens. 538 samples. Type: Expression profiling by array.
Analysis of gene expression changes in patient-derived gastric cancer cells after anticancer drug treatment or ALDH1A3 knockdown
GEO Series GSE139331. Homo sapiens. 11 samples. Type: Expression profiling by array.
Perturbation-informed signatures from crosswise integration of transcriptome and chromatin accessibility analyses predict susceptibility to candidate anticancer drugs (cisplatin validation dataset)
GEO Series GSE207612. Homo sapiens. 32 samples. Type: Expression profiling by high throughput sequencing; Genome binding/occupancy profiling by high throughput sequencing.
Drug-induced change in gene expression across NCI-60 cell lines after exposure to 15 anticancer agents for 2, 6 and 24h (sorafenib)
GEO Series GSE116448. Homo sapiens. 524 samples. Type: Expression profiling by array.
The Anticancer Mechanism of the Ribonucleotide Reductase Inhibiting Drug COH29 Involves Suppression of DNA Repair
GEO Series GSE55004. Homo sapiens. 8 samples. Type: Expression profiling by array.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.